Modelling to Market – Enabling Smarter, Faster Injector Development

Modelling to Market – Enabling Smarter, Faster Injector Development

Wednesday, October 29, 2025 12:05 PM to 12:20 PM · 15 min. (CET)
Hall 8 - 8.0J60
Packaging & Device Innovation

Information

Explore how predictive modelling can be integrated across the injector development lifecycle – from design and usability testing to regulatory submissions. This session highlights how modelling supports risk reduction, regulatory confidence, and faster market access.

Sector
Packaging & Device Innovation
Catalent6.1B70Catalent is a leading global CDMO whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually.

Registered attendees

Charlie Bowen
Charlie Bowen
Device EngineerPfizer
Valerie Chambard
Valerie Chambard
Supply Chain leadCEPI